Author

Lei Shi

University of Wisconsin–MadisonORCID 0000-0001-5664-1462Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Lei Shi5 papers · Chinese PLA General Hospital

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Christian M. CapitiniiD· 3 shared Aicha E. QuamineiD· 1 shared Amanda G. SheaiD· 1 shared Amy K. ErbeiD· 1 shared Anastasia A Griggs· 1 shared Andrea PennatiiD· 1 shared Andreanna Wilke· 1 shared Andrew Ollendorff· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Christian M. CapitiniORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 24, 2026

Low-dose radiopharmaceutical therapy enhances the efficacy of B7-H3 CAR T cells in murine metastatic neuroblastoma

Amanda G. Shea, Andrew Ollendorff, Andreanna Wilke…·Quaovi H. Sodji

This study shows that low-dose radiopharmaceutical therapy enhances the effectiveness of B7-H3 CAR T cells in treating metastatic neuroblastoma in mice.

DOI 10.64898/2026.09.16.751528

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 17, 2025

Synthesis of mRNA lipid nanoparticles for engineering GD2 CAR T and CAR NK cells against neuroblastoma

Chih-Chun Chang, Lei Shi, Soon Ho Choi…·Jacques Galipeau

This study develops mRNA lipid nanoparticles to deliver GD2 CAR genes to T and NK cells, showing effective neuroblastoma targeting and killing in vitro.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewedDec 1, 2025

TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplant

Aicha E. Quamine, Evan L. Dray, Nicholas R Mohrdieck…·Christian M. Capitini

This study shows that combining TIM-3 blockade with ex vivo stimulated allogeneic NK cells improves survival and reduces tumor growth in a murine neuroblastoma model after allo-HCT without increasing GVHD.

2 citations

mouseproteomics

𝕏 PostBluesky